about
Collaborative enhancement of antibody binding to distinct PECAM-1 epitopes modulates endothelial targetingSystems approaches to design of targeted therapeutic delivery.Dual targeting of therapeutics to endothelial cells: collaborative enhancement of delivery and effect.Mechanism of Collaborative Enhancement of Binding of Paired Antibodies to Distinct Epitopes of Platelet Endothelial Cell Adhesion Molecule-1.Collaborative Enhancement of Endothelial Targeting of Nanocarriers by Modulating Platelet-Endothelial Cell Adhesion Molecule-1/CD31 Epitope Engagement.Vascular Accessibility of Endothelial Targeted Ferritin Nanoparticles.Reduction of nanoparticle avidity enhances the selectivity of vascular targeting and PET detection of pulmonary inflammationAdvanced drug delivery systems for antithrombotic agents.Molecular engineering of high affinity single-chain antibody fragment for endothelial targeting of proteins and nanocarriers in rodents and humans.Platelet endothelial cell adhesion molecule targeted oxidant-resistant mutant thrombomodulin fusion protein with enhanced potency in vitro and in vivo.Heart failure associated with sunitinib: lessons learned from animal models.Endothelial nanomedicine for the treatment of pulmonary disease.Vascular immunotargeting to endothelial determinant ICAM-1 enables optimal partnering of recombinant scFv-thrombomodulin fusion with endogenous cofactorTargeting thrombomodulin to circulating red blood cells augments its protective effects in models of endotoxemia and ischemia-reperfusion injury.Endothelial targeting of liposomes encapsulating SOD/catalase mimetic EUK-134 alleviates acute pulmonary inflammation.Dynamics of intrapulmonary bacterial growth in a murine model of repeated microaspirationEndothelial targeting of nanocarriers loaded with antioxidant enzymes for protection against vascular oxidative stress and inflammation.Targeting to endothelial cells augments the protective effect of novel dual bioactive antioxidant/anti-inflammatory nanoparticles.Site-Specific Modification of Single-Chain Antibody Fragments for Bioconjugation and Vascular Immunotargeting.Mechanisms that determine nanocarrier targeting to healthy versus inflamed lung regions.Ferritin Nanocages with Biologically Orthogonal Conjugation for Vascular Targeting and Imaging.In vitro and in silico analysis of annexin V binding to lymphocytes as a biomarker in emergency department sepsis studiesFlexible Nanoparticles Reach Sterically Obscured Endothelial Targets Inaccessible to Rigid NanoparticlesICAM-1-targeted thrombomodulin mitigates tissue factor-driven inflammatory thrombosis in a human endothelialized microfluidic modelMolecularly Engineered Nanobodies for Tunable Pharmacokinetics and Drug DeliveryVascular Targeting of Radiolabeled Liposomes with Bio-Orthogonally Conjugated Ligands: Single Chain Fragments Provide Higher Specificity than AntibodiesImmunolocalization of anion transporter Slc26a7 in mouse kidney
P50
Q28482282-7DC9F884-E6FE-4A12-ACF8-B66D9721F9A9Q35623160-D4A676C7-3710-4EBE-99BE-611DEE7FFF98Q35878956-8A65CC72-5E3E-4CEA-93C3-1286E4A6A032Q36248811-32F8068A-E138-49BF-A72F-D56B9CF96BE7Q36601477-1A8B3C53-B200-472C-BC0A-C1CFBFED485EQ36693096-33BFF467-5F6F-4853-BDF6-3B347D90B304Q36721811-EBA4AEAD-75FA-4CC8-A642-1EE2F0E9375BQ37132620-52C52529-37A4-4D7F-9577-32AC7F5DA50FQ37134054-A5681CC3-FB5F-4161-8B71-9E19C7E4B752Q37252049-7E066D73-388F-4F10-8FD8-B595CABB1B82Q37914048-E0A458A3-CFB3-4A7D-A23E-04EEDB4FA4C7Q38267984-AE728D24-FC14-465D-9BCF-8F0E0BD968D8Q39061982-2D69AA9D-05F5-4CDC-B4F9-5450A0C87DEEQ40455117-512B4D39-EB48-44ED-9AC3-FEF6F7709A87Q41351381-305DD731-D5B7-420D-8CD5-034CE5891522Q41854363-D2DED3FF-E4BF-4AAE-B8FF-2A4CE54D55EAQ42160647-CECC384F-1408-4FDF-89A4-E472E639190FQ42206588-FE43BB5F-EE06-4B85-9074-F64F30B07B33Q47336012-5ABC1560-12E5-4615-855B-E91D558637D4Q48003088-700D9D8D-7268-4009-B88D-B4D8FC550F12Q50077661-80F73CEA-95DB-4769-92DB-4440C26A0BE7Q80227287-E5D2C3F3-680F-4452-A5C7-993CE9153996Q89339996-4D5F9B78-6841-4700-80B1-7EF86AEE6A0DQ89777201-6AC61257-EE54-4F0C-9B26-C7CDE3EFFAF8Q90298981-75C93D6B-8CAE-480A-9FBB-AD801DE03535Q91622748-43634C9A-6504-4388-A46C-65780A443972Q94462418-753A62BD-5DA6-4F36-B29B-5242B713F6FD
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Colin F Greineder
@ast
Colin F Greineder
@en
Colin F Greineder
@es
Colin F Greineder
@nl
Colin F Greineder
@sl
type
label
Colin F Greineder
@ast
Colin F Greineder
@en
Colin F Greineder
@es
Colin F Greineder
@nl
Colin F Greineder
@sl
prefLabel
Colin F Greineder
@ast
Colin F Greineder
@en
Colin F Greineder
@es
Colin F Greineder
@nl
Colin F Greineder
@sl
P106
P21
P31
P496
0000-0001-9740-7672